Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration (FDA) approval as a treatment for obstructive sleep apnea among adults with obesity.
Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication ... also supports the FDA’s new authorization.
The first medication for obstructive sleep apnea has been approved ... The drug is to be paired with a reduced-calorie diet and increased physical activity, the FDA noted. Sally Seymour, M.D ...